Of note is the reported finding that the serine protease kallikrein 4 (KLK4), which promotes prostate cancer growth, activated both the AR and mTORC1 axis due to negative interplay of KLK4 with the transcription factor PLZF (promyelocytic leukemia zinc finger) [34]. Here, ZBTB16 is linked to prostate carcinoma.